Cognex Delivers Q2 2026 Results—Testing the AI Growth Thesis

What happened

Cognex Corporation reported second-quarter 2026 results after the market close on August 5, 2026, providing the first major checkpoint for the AI-led growth narrative. The company had guided for revenue of $280–300 million and adjusted EBITDA margin of 28–31%, figures that would trigger a rating change in our DeepValue framework depending on whether they were met or missed. Alongside the numbers, investors will scrutinize management’s commentary for evidence of OneVision and In-Sight AI platform adoption moving beyond pilots into multi-site deployments. The stock’s valuation at 73.5x P/E leaves no tolerance for disappointment, with the market already pricing broad AI-driven order acceleration. This report thus serves as a critical re-assessment point, with the potential to shift our WAIT rating to BUY or SELL based on the actual outcomes.

Implication

If revenue exceeded $280M and margins held above 28%, with management citing material OneVision-driven deployments, the bull case probability rises, and we would consider upgrading to BUY on a pullback. However, a revenue miss or margin below 28% would signal that AI monetization is delayed, undermining the current multiple and pushing us to SELL. Even a slight beat may not be enough if automotive remains weak and logistics growth fades. The results provide the clearest signal yet on whether Cognex’s AI transition is translating into durable earnings power. We await full details before making any rating change.

Thesis delta

Q2 2026 actuals are the decisive test for our WAIT thesis. A strong quarter with AI evidence shifts base-case probability higher, suggesting an upgrade opportunity; any shortfall reinforces the bear case and compels a downgrade.